Update in Hospital Medicine

Similar documents
Update in Hospital Medicine

Year in Review

10/27/13. Update in Hospital Medicine Update in Hospital Medicine Update in Hospital Medicine 2013

Update in Hospital Medicine. Update in Hospital Medicine 2009

UPDATE IN HOSPITAL MEDICINE

Non-invasive Positive Pressure Mechanical Ventilation: NIPPV: CPAP BPAP IPAP EPAP. My Real Goals. What s new in 2018? OMG PAP?

Top Papers in Cri-cal Care Janna Landsperger, ACNP- BC

Updates in Critical Care Sepsis, Fluids, Epi and Long-Term Outcomes

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

The Use of Metabolic Resuscitation in Sepsis

Surgery Grand Rounds. Non-invasive Ventilation: A valuable tool. James Cromie, PGY 3 8/24/09

Dyspnea: Should we use BIPAP?

Emergency Medicine High Velocity Nasal Insufflation (Hi-VNI) VAPOTHERM POCKET GUIDE

Inflammatory Statements

No conflicts of interest

Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill

Antioxidant Dosing and Micronutrient Management in the Intensive Care Unit

Top Sepsis Studies

OHSU. Update in Sepsis

Keeping Patients Off the Vent: Bilevel, HFNC, Neither?

PEEP recruitment maneuver

Tracheal Intubation in ICU: Life saving or life threatening?

MAKING SENSE OF IT ALL AUGUST 17

Sedation Management AfteR Tracheostomy (SMART) study

Systems differ in their ability to deliver optimal humidification

NIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity

Current State of Pediatric Sepsis. Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018

Update in Critical Care Medicine

Stuart Murdoch Consultant Intensive Care St. James s University Hospital March 2010

Kugelman A, Riskin A, Said W, Shoris I, Mor F, Bader D.

CAP, HCAP, HAP, VAP. 1. In 1898, William Osler described community-acquired pneumonia as:

Update in Hospital Medicine 2013

Update in Hospital Medicine 2013

Post-Resuscitation Care. Prof. Wilhelm Behringer Center of Emergency Medicine University of Jena

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

Disclosure. Learning Objectives. Bernadette Zelaya, RRT. Area Clinical Manager

Postoperative Respiratory failure( PRF) Dr.Ahmad farooq

Optimize vent weaning and SBT outcomes. Identify underlying causes for SBT failures. Role SBT and weaning protocol have in respiratory care

Steroids for ARDS. Clinical Problem. Management

Vasopressors for shock

THE BEST I HAVE READ THIS YEAR (IN PULMONARY AND CRITICAL CARE)

Best of Pulmonary Jennifer R. Hucks, MD University of South Carolina School of Medicine

What is the next best step?

IICU Staff Meeting Minutes May 15 and 16, 2013 IICU Conference Room

Trial protocol - NIVAS Study

Sepsis Management: Past, Present, and Future

Andrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015

Hospital Transition Management. Barbara Wood, BSN, MBA

Facilitating EndotracheaL Intubation by Laryngoscopy technique and Apneic Oxygenation Within the Intensive Care Unit (FELLOW)

The use of proning in the management of Acute Respiratory Distress Syndrome

Transfusion & Mortality. Philippe Van der Linden MD, PhD

Early Recognition and Timely Management of Sepsis Amid Changes in Definitions

Outbreak Case Study. Ralstonia Outbreak Investigation Background

11/3/11 VS. Updated literature since October Process: CME collaborative review of journals. Three hospitalists ranked articles

Noninvasive Ventilation: Non-COPD Applications

Rapid Response Teams. January 17, Safe Table Webinar

CORTICOSTEROID USE IN SEPTIC SHOCK THE ONGOING DEBATE DIEM HO, PHARMD PGY1 PHARMACY RESIDENT VALLEY BAPTIST MEDICAL CENTER BROWNSVILLE

Rethinking Arterial Catheters in the ICU. Allan Garland, MD, MA Professor of Medicine & Community Health Sciences University of Manitoba

Prone ventilation revisited in H1N1 patients

Rapid Response Teams and End-of-Life Care. James Downar, MDCM, MHSc, FRCPC Critical Care and Palliative Care, University Health Network, Toronto

How did I decide on the topics?

Alma Mater University of Bologna. Respiratory and Critical Care Sant Orsola Hospital, Bologna, Italy

9/15/2017. Disclosures. Heated High Flow Nasal Cannula: Hot Air or Optimal Noninvasive Support? Objectives. Aerogen Pharma

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program

PAPER DE LA VNI EN LA RETIRADA DE LA VENTILACIÓ INVASIVA I FRACÀS D EXTUBACIÓ

Tissue is the Issue. PEEP CPAP FiO2 HFNC PSV HFNC. DO 2 = CO [(Hb x 1.34) SaO PaO 2 ] perfusione

NIV use in ED. Dr. Khalfan AL Amrani Emergency Resuscitation Symposium 2 nd May 2016 SQUH

Sepsis. Reliability- can we achieve Dr Ron Daniels

2016 Year in Review: Noninvasive Ventilation

Year in Review Intensive Care Training Program Radboud University Medical Centre Nijmegen

Steroid in Paediatric Sepsis. Dr Pon Kah Min Hospital Pulau Pinang

What is sepsis? RECOGNITION. Sepsis I Know It When I See It 9/21/2017

Update in Hospital Medicine Bradley A. Sharpe, MD Assistant Clinical Professor UCSF Division of Hospital Medicine

Nutrition and Sepsis

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

Steroids in ARDS: if, when, how much? John Fowler, MD, FACEP Dept. of Emergency Medicine Kent Hospital, İzmir, Türkiye

The Association Between Oxygenation Thresholds and Mortality During Extracorporeal Life Support

JAMA. 2016;315(8): doi: /jama

Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia

Stressed Out: Evaluating the Need for Stress Ulcer Prophylaxis in the ICU

Pneumonia Community-Acquired Healthcare-Associated

Supplementary appendix

VS. Present updated literature since April Process: CME collaborative review of journals. Four hospitalists ranked articles

ECMO: a breakthrough in care for respiratory failure. PD Dr. Thomas Müller Regensburg no conflict of interest

Wanchai Wongkornrat Cardiovascular Thoracic Surgery Siriraj Hospital Mahidol University

How do we define pneumonia?

The Berlin Definition: Does it fix anything?

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Biomarkers in sepsis. Dr S Omar University of Witwatersrand CHBAH Bara ICU

Pulmonary Rehabilitation and Palliative Care. Sindhu Mukku, MD Pulmonary/Critical Care Fellow, PGY-5 February 26, 2013

FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL

Sepsis-3: clarity or confusion

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand

Does this patient need ICU?

Sepsis in primary care. Sarah Bailey, Emma Evans, Nicola Shoebridge, Fiona Wells

Community Acquired & Nosocomial Pneumonias

Common Confounding Consults In Pulmonary & Critical Care

Transcription:

Update in Hospital Medicine 2017-2018 Brad Sharpe, MD SFHM UCSF Division of Hospital Medicine 2017-2018 Updated literature March 2017 March 2018 Process: CME collaborative review of journals Including ACP J. Club, J. Watch, etc. Independent analysis of article quality Thank you to Brad Monash, Ed Vasilevskis, Rachel Thompson, Chad Miller 1

2017-2018 Chose articles based on 3 criteria: 1) Change your practice/teaching 2) Modify your practice/teaching 3) Confirm your practice/teaching Hope to not use the words: Student s t-test, meta-regression, Mantel-Haenszel statistical method, etc. Focus on breadth, not depth 2017-2018 Major reviews/short takes Case-based format Multiple choice questions Promote retention 2

Syllabus/Bookkeeping No conflicts of interest Final presentation available by email sharpeb@medicine.ucsf.edu COPD Exacerbation & NIPPV Question: Design: What is the benefit of NIPPV over usual care in COPD exacerbations? Meta-analysis, RCT of NIPPV vs. usual care in adults w/ COPD exacerbation Standard treatments for COPD Enrolled if ph < 7.35 + PCO 2 > 45mmHg Examined ph < 7.35 and ph < 7.30 Osadnik CR, et al. Cochrane.2017;7:CD004104. Update in Hospital Medicine 3

Results Total of 17 studies, 1264 patients; age 67 yo Moderate quality evidence Outcome NIPPV Usual Care Risk Ratio Mortality 9.7% 18.3% 0.54* (0.38-0.76) Intubation 12.0% 33.1% 0.36* (0.28-0.46) Results true for ph < 7.35 & ph < 7.30 NIPPV with shorter LOS (- 3.39 days) Complications more common but mild COPD Exacerbation & NIPPV Question: What is the benefit of NIPPV over usual care in COPD exacerbations? Design: Meta-analysis, RCT of NIPPV vs. usual care in adults w/ COPD exacerbation Conclusion: NIPPV decreases mortality & intubation vs. usual care; may cut LOS (3 days); True for ph < 7.35 Comments:Meta-analysis, moderate quality overall Duration of use unclear NIPPV may be underused Consider in patients with ph < 7.35 Osadnik CR, et al. Cochrane.2017;7:CD004104. Update in Hospital Medicine 4

Short Take: PE in Syncope One meta-analysis and two retrospective studies Prevalence of PE in the setting of syncope is probably: 1-2% Multiple flaws with the prior study Consider PE as a cause for syncope A routine evaluation for PE in syncope is not warranted Oqab Z, et al. Am J Emerg Med. Sept 2017. Costantino G, et al. JAMA Int Med. March 2018. Epstein D, et al. PLoS One. March 2018. Short Take: Orthostatic Vital Signs Prospective cohort study of 11,429 middle-aged adults (age 44-66 years) Orthostatic vital signs were checked every 30 seconds Orthostatic hypotension within one minute of standing was most strongly associated with: -- Dizziness -- Falls -- Fracture -- Syncope -- Car crashes -- Death Juraschek SP, et al. JAMA Intern Med.2017;177:1316. 5

Probiotics for C diff. Question: Design: What is the role for probiotics in the prevention of C difficile infection? Syst. review & meta-analysis of randomized, controlled trials Probiotics vs. other to prevent C diff. Included any strain (16 types) & any dose of probiotic Some risk of bias in some studies Goldenberg JZ, et al. Cochrane Syst Rev. 2017 Dec 19. Update in Hospital Medicine Probiotics for C. difficile A total of 31 trials, 8672 patients Outcome Probiotics Other p All Patients 1.5% 4.0% <0.05* Baseline Risk Risk Ratio p > 5% 0.30 (3.1% v 11.6%) <0.01* Antibiotic-associated diarrhea less in probiotics group Adverse events lower in probiotics group Detection of C diff in the stool was the same No difference with different probiotics Goldenberg JZ, et al. Cochrane Syst Rev. 2017 Dec 19. * MODERATE 6

Probiotics for C diff. Question: What is the role for probiotics in the prevention of C difficile infection? Design: Syst. review & meta-analysis; probiotics vs. other to prevent C diff. Conclusion: Probiotics prevent C diff; main benefit in high-risk (>5%) patients Less diarrhea, fewer side effects overall Comments: Some risk of bias, moderate quality overall Probiotics likely prevent C diff; Avoid in some patients (immunocompromised) Unclear type or dose; cost-effectiveness? Consider implementing protocols Goldenberg JZ, et al. Cochrane Syst Rev. 2017 Dec 19. Update in Hospital Medicine Case Summary Definitely 1. Recognize PE may not be that common in patients admitted with syncope. Consider 1. Using BiPAP in patients with a COPD exacerbation and hypercarbia (ph < 7.35). 2. Checking orthostatic vital signs at one minute. 3. Starting probiotics in patients at high-risk for C diff. 7

Short take: Hydrocortisone, Vit C, Thiamine Retrospective before-after study, 94 patients with severe sepsis or septic shock Half (47 pts) received hydrocortisone, vitamin C, and thiamine; 47 pts received usual care Hospital mortality Usual practice 40.4% (19/47) Vitamin C cocktail 8.5% (4/47) SOFA scores decreased faster, less RRT for AKI, and they had shorter duration of vasopressors Marik PE, et al. Chest. 2017 Jun;151(6):1229-1238. Cultures in GNR Bacteremia Question: What is the value of follow-up blood cultures (FUBC) in GNR bacteremia? Design: Retrospective analysis, 500 pts w/ true bacteremia; examined FUBC & predictors of persistent bacteremia Canzoneri C, et al. Clin Inf Dis. 2017;July. 8

Results A total of 383 patients had FUBC drawn (77%) Total of 37% of GNR bacteremia had FUBC All patients Gram positive cocci (GPC) Gram negative rods (GNR) Positive FUBC 14% (55/383) 20.9% (43/206) 5.7% (8/140) Fever when FUBC drawn was predictive Cultures in GNR bacteremia Question: What is the value of follow-up blood cultures (FUBC) in GNR bacteremia? Design: Retrospective analysis, 500 pts w/ true bacteremia; examined FUBC & predictors of persistent bacteremia Conclusion:FUBC are common in GNR bacteremia; Low yield in GNR only 5.7% positive; fever at time of FUBC predictive for GNR Comment: Retrospective, single center, indications for initial and FUBC unknown In general, do not repeat blood cultures in GNR bacteremia Consider if persistent fever, lack source control 9

Short take: Oral Antibiotics & Bacteremia Goal: use bioavailable agents whenever possible (Choosing Wisely) Narrative review of the literature Variable results depending on organism: MSSA/MRSA: Two weeks of IV treatment Strep pneumonia: probably safe GNRs: probably safe Hale AJ, et al. J Hosp Med. 2018 Feb 28. Short Take: Blood Culture Yield In a prospective multicenter observational cohort study, 1,943 hospitalized patients who had blood cultures drawn (for any reason) were followed. Among patients with 1) Poor food consumption and 2) Shaking chills, The incidence of true bacteremia was 47.7%. Komatsu T, et al. J. Hosp. Med. 2017 July;12(7):510-516. 10

Short Take: Blood Culture Yield In patients with: 1) Normal food consumption and 2) No shaking chills, The incidence of true bacteremia was 2.4%. Komatsu T, et al. J. Hosp. Med. 2017 July;12(7):510-516. Short Take: Blood Culture Yield Normal food consumption had a negative likelihood ratio of 0.18 (95% CI, 0.17-0.19) for excluding true bacteremia. The presence of shaking chills had a positive likelihood ratio of 4.78 (95% CI, 4.56-5.00) for true bacteremia. Komatsu T, et al. J. Hosp. Med. 2017 July;12(7):510-516. 11

Case Summary Consider 1. Hydrocortisone, vitamin C and thiamine in the management of sepsis (pending further studies) 2. Not routinely obtaining follow-up blood cultures for GNR bacteremia. 3. Oral antibiotics may be used to treat gramnegative rod bacteremia 4. Deferring blood cultures if the patient is eating well and without rigors. High-Flow Nasal Cannula Heated and humidified oxygen delivered at rates of up to 60L/min Benefits Patient comfort Mobilize secretions Decreased entrapment of room air Washout of dead space PEEP Deliver ~ 100% FiO2 Update in Hospital Medicine 12

High-Flow Nasal Cannula Question: What are the benefits of high-flow nasal cannula (HFNC) in hypoxic respiratory failure? Design: Syst-rev & meta-analysis; 18 studies, 3,881 patients with hypoxic resp. failure; RCTs (12), prospective, retrospective Compared HFNC vs. usual oxygen therapy or NIPPV Goal was O2 saturation > 92% Ni Y, et al. Chest. 2017;151:764. Results Medical & surgical causes of respiratory failure No evidence of publication bias Outcome HFNC vs. O 2 HFNC vs. NIPPV Intubation 0.47* (0.27-0.84) ICU mortality 0.65 (0.37-1.13) 0.73 (0.47-1.13) 0.63 (0.34-1.18) Reintubation: O 2 > HFNC = NIPPV No data on patient comfort Ni Y, et al. Chest. 2017;151:764. * P < 0.05) 13

High-Flow Nasal Cannula Question: What are the benefits of high-flow nasal cannula in hypoxic respiratory failure? Design: Syst-rev & meta-analysis; 18 studies, 3,881 patients with hypoxic resp. failure; Conclusion: HFNC may decrease intubation in hypoxic respiratory failure vs. usual oxygen delivery No difference when compared to NIPPV; No change in ICU mortality Comments: Statistical heterogeneity; many causes Better than usual oxygen delivery; no worse than NIPPV, more comfortable Can be standard for patients with hypoxic respiratory failure Short take: Hospitalists & Mortality Retrospective study large Medicare database Mortality in 1 st -year vs. 2 nd -year & beyond Controlled for multiple factors Hospitalists in their 1 st -year had a higher: In-hospital mortality (3.33% v 2.96%, p<0.05) 30-day mortality (9.97% v 10.5%, p<0.05) There was no change in mortality after the second year Goodwin JS, et al. JAMA Int Med. Feb 2018;178(2). 14

Statements of Empathy Question: What is the impact of empathy statements on hospitalized patients? Design: Prospective qualitative/quantitative; Audio-recorded admit encounters Assess anxiety & communication ratings Recorded empathic responses to negative emotions Weiss R, et al. J Hosp Med. Oct 2017;12(10). Results A total of 76 patients, 27 admitting attendings Range negative emotions 0-14 (median 1) Empathic statements improved ratings for: Covering points of interest Feeling listened to Feeling cared about Overall trust Reduced STAI-S anxiety score No change in encounter length (median 19 min.) Weiss R, et al. J Hosp Med. Oct 2017;12(10). 15

Statements of Empathy Question: What is the impact of empathy statements on hospitalized patients? Design: Prospective qualitative/quantitative; Audiorecorded admit encounters Assess anxiety & communication ratings Conclusion: Empathic statements improved ratings of provider communication; reduced anxiety No change in time spent Comments: Small study, one hospital Consistent with prior studies Low (no?) cost intervention to improve patient satisfaction Weiss R, et al. J Hosp Med. Oct 2017;12(10). Short Take: Smartphone Sign In a prospective cohort study of 221 patients on a surgical ward, smartphone use was recorded daily with other clinical data. After controlling for demographics (e.g. age) and clinical data, patients using their smartphone: Were 5.29 (95% CI, 2.24-12.84) more likely to be discharged The negative predictive value was 93.5%. Hoffman R, et al. J HospMed.2017;12:XXX. Update in Hospital Medicine 16

Case Summary Definitely 1. Use high-flow nasal cannula for hypoxic respiratory failure. 2. Use statements of empathy. Consider 1. First-year hospitalists may have a higher mortality. 2. Patients using their smartphone may be ready for discharge. Case Summary Definitely 1. Recognize PE may not be that common in patients admitted with syncope. Consider 1. Using BiPAP in patients with a COPD exacerbation and hypercarbia (ph < 7.35). 2. Checking orthostatic vital signs at one minute. 3. Starting probiotics in patients at high-risk for C diff. 17

Case Summary Consider 1. Hydrocortisone, vitamin C and thiamine in the management of sepsis (pending further studies) 2. Not routinely obtaining follow-up blood cultures for GNR bacteremia. 3. Oral antibiotics may be used to treat gramnegative rod bacteremia 4. Deferring blood cultures if the patient is eating well and without rigors. 18